Skip to content

The study of the effects of intellectual disability and oral antiepileptic drugs on awaking from general anesthesia

The study of the effects of intellectual disability and oral antiepileptic drugs on emergence from total intravenous anesthesia - The effects of intellectual disability and antiepileptic drugs on emergence from total intravenous anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000039855
Enrollment
60
Registered
2020-04-01
Start date
2020-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental patients undergoing total intravenous anesthesia

Interventions

None listed

Sponsors

Okayama University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)BMI is less than 30, 2)ASA is PS 1 or 2, 3)Anesthesia time will be less than 5 hours, 4)Patients undergoing dental treatment or minor oral surgery, 5)No need receiving opioid analgesics for postoperative analgesia

Exclusion criteria

Exclusion criteria: 1)Patients with contraindications for propofol, remifentanil, rocuronium, 2)Patients who are judged to be inappropriate for study participation

Design outcomes

Primary

MeasureTime frame
1)Blood concentration of propofol at the discontinuation of propofol and tracheal extubation, 2)Time from the discontinuation of propofol to tracheal extubation and 3)BIS value at tracheal extubation

Secondary

MeasureTime frame
1)Propofol amount and average infusion rate of propofol, 2)Estimated blood concentration of propofol at the discontinuation of propofol and tracheal extubation, 3)Remifentanil amount and average infusion rate of remifentanil, 4)BIS values before & during anesthesia, and at the discontinuation of propofol.

Countries

Japan

Contacts

Public ContactHitoshi Higuchi

Okayama University Hospital Department of Dental Anesthesiology

higuti@md.okayama-u.ac.jp086-235-6721

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026